Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Total 13F shares
-
29,619,793
-
Share change
-
-250,649
-
Total reported value
-
$422,555,895
-
Put/Call ratio
-
123%
-
Price per share
-
$14.27
-
Number of holders
-
162
-
Value change
-
-$29,484,537
-
Number of buys
-
88
-
Number of sells
-
78
Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q2 2021
As of 30 Jun 2021,
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by
162 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,619,793 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Farallon Capital Management LLC, STATE STREET CORP, Chescapmanager LLC, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, Assenagon Asset Management S.A., DISCIPLINED GROWTH INVESTORS INC /MN, and Nuveen Asset Management, LLC.
This page lists
162
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.